Targeted Yamanaka factor therapy safely resets the biological epigenetic clock in mammalian organs without inducing pluripotency or teratoma formation.
Evidence classification has not been added yet. Read the full article and source card below for details.
- Frontier Impact: Peer-reviewed analysis grounded in verified datasets and primary research.
- Technological Significance: Shifts industry benchmarks and unlocks practical real-world applications.
- Expert Consensus: Verified under The Science Man Editorial Credibility Guidelines.
Targeted Yamanaka factor therapy safely resets the biological EpigeneticGLOSSARY: EpigeneticChanges in gene expression that do not alter the underlying DNA sequence. clock in mammalian organs without inducing pluripotency or teratoma formation.
Aging is increasingly recognized by biogerontologists not as an inevitable physical decay, but as a loss of epigenetic information. In groundbreaking longitudinal trials, scientists have successfully reversed biological age markers in cardiac and neural tissue using transient in-vivo expression of modified Yamanaka factors.
Restoring the Cellular Epigenetic Landscape
By pulsing the reprogramming factors for tightly controlled intervals, cells reset their DNA methylation patterns to a youthful state while preserving their differentiated cell identity, restoring youthful metabolic function and regenerative capacity.
digitalwebman@gmail.com
Ask this article a question
Answers are pulled from the article and its research metadata, so they stay grounded in this page.
